Skip to main content

Ionis to present at upcoming investor conferences

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences:

  • 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, 2025
  • Bank of America 2025 Health Care Conference on Wednesday, May 14, 2025
  • 2025 RBC Capital Markets Global Healthcare Conference on Wednesday, May 21, 2025

A live webcast of these presentations can be accessed on the Investors & Media section of the Ionis website at https://ir.ionis.com/events-and-presentations/upcoming-events. Replays will be available on the Ionis website within 48 hours and will be archived for a limited time.

About Ionis Pharmaceuticals

For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has six marketed medicines and a leading pipeline in neurology, cardiology and select areas of high patient need. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter), LinkedIn and Instagram.

Contacts

Ionis Pharmaceuticals Investor Contact:

D. Wade Walke, Ph.D. – ir@ionis.com760-603-2331



Ionis Pharmaceuticals Media Contact:

Hayley Soffer – media@ionis.com – 760-603-4679

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.73
+0.34 (0.16%)
AAPL  263.75
-0.97 (-0.37%)
AMD  190.95
-7.67 (-3.86%)
BAC  49.97
+0.16 (0.32%)
GOOG  303.56
-2.80 (-0.91%)
META  655.08
+1.52 (0.23%)
MSFT  403.93
+5.38 (1.35%)
NVDA  180.05
-2.43 (-1.33%)
ORCL  149.01
-0.24 (-0.16%)
TSLA  392.43
-10.89 (-2.70%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.